- Home
- SPAI vs ACHL Comparison
SPAI vs ACHL Comparison
Compare SPAI & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- ACHL
- Stock Information
- Founded
- SPAI 2021
- ACHL 2016
- Country
- SPAI United States
- ACHL United Kingdom
- Employees
- SPAI N/A
- ACHL N/A
- Industry
- SPAI Industrial Specialties
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPAI Health Care
- ACHL Health Care
- Exchange
- SPAI Nasdaq
- ACHL Nasdaq
- Market Cap
- SPAI 51.7M
- ACHL 47.5M
- IPO Year
- SPAI 2024
- ACHL 2021
- Fundamental
- Price
- SPAI $2.80
- ACHL $1.13
- Analyst Decision
- SPAI
- ACHL Buy
- Analyst Count
- SPAI 0
- ACHL 2
- Target Price
- SPAI N/A
- ACHL $4.00
- AVG Volume (30 Days)
- SPAI 242.7K
- ACHL 137.7K
- Earning Date
- SPAI 11-14-2024
- ACHL 11-14-2024
- Dividend Yield
- SPAI N/A
- ACHL N/A
- EPS Growth
- SPAI N/A
- ACHL N/A
- EPS
- SPAI N/A
- ACHL N/A
- Revenue
- SPAI $1,559,057.00
- ACHL N/A
- Revenue This Year
- SPAI N/A
- ACHL N/A
- Revenue Next Year
- SPAI N/A
- ACHL N/A
- P/E Ratio
- SPAI N/A
- ACHL N/A
- Revenue Growth
- SPAI 35.50
- ACHL N/A
- 52 Week Low
- SPAI $1.56
- ACHL $0.63
- 52 Week High
- SPAI $6.50
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- SPAI N/A
- ACHL 51.10
- Support Level
- SPAI N/A
- ACHL $1.10
- Resistance Level
- SPAI N/A
- ACHL $1.16
- Average True Range (ATR)
- SPAI 0.00
- ACHL 0.04
- MACD
- SPAI 0.00
- ACHL -0.01
- Stochastic Oscillator
- SPAI 0.00
- ACHL 30.00
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Safe-Pro USA.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.